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LETTERS
Mycobacterium 
novocastrense–
associated 
Pulmonary and 
Wound Infections
To the Editor: Although the 
clinical role of nontuberculous 
mycobacteria has long been 
appreciated (1), the high endemicity 
of tuberculosis (TB) in developing 
countries has overshadowed the 
emergence of these organisms. 
They are simply dismissed as being 
contaminants or are misidentiﬁ  ed as 
Mycobacterium tuberculosis (2).
No report on M. novocastrense 
has been published since its original 
description in 1997 (3), except for a 
study in France by N’Guessan et al. (4). 
That study initiated speculation about 
the possible role of this bacterium in 
the etiology of human infection. We 
report isolation of M. novocastrense 
in 2 independent clinical cases—1 
from tissue biopsy specimen of an 
apparently healthy adult, the other 
from bronchoalveolar lavage of an 
HIV-infected patient—that will cast 
light on the clinical relevance of this 
rare species.
Case-patient 1, a 60-year-old 
woman, was referred to a hospital 
because of high fever, productive 
cough, thoracic pain, and noticeable 
weight loss. After her husband’s AIDS-
related death in a state prison, HIV 
infection had been diagnosed in this 
case-patient. At admission, laboratory 
testing showed negative tuberculin 
skin test result, lymphopenia, an 
elevated C-reactive protein level of 76 
mg/L, an erythrocyte sedimentation 
rate of 73 mm/h, a viral load of 500 
copies/mL, and negative blood culture 
for bacterial growth. Her outpatient 
records indicated that she empirically 
was given numerous courses of 
antimicrobial drugs because of a 
provisional diagnosis of bacterial 
pneumonia, but her condition did 
not improve. Subsequent hospital 
referral was prompted by worsening 
of her symptoms. With a diagnosis 
of suspected TB, bronchoalveolar 
lavage  ﬂ   uid was collected. Direct 
microscopic examination of the 
specimen showed acid-fast bacilli 
with subsequent formation of typical 
colonies of a relatively rapidly growing 
photochromogenic  Mycobacterium 
spp. on Löwenstein-Jensen (LJ) 
medium. The patient was treated with 
amikacin, and her condition markedly 
improved.
Case-patient 2, a 23-year-old 
woman, sought care for a 6-month 
history of soft tissue swelling in her 
left leg resulting from an accidental 
injury in a paddy ﬁ  eld.  The  lesion 
had not been treated and subsequently 
increased in size. The large nodule 
self-ruptured and excreted yellow-pale 
pus. She was prescribed minocycline 
by her general practitioner, but the 
lesion did not resolve. When the patient 
arrived at the hospital, her clinical and 
laboratory assessments were normal. 
She had negative test results for HIV, 
hepatitis C, and hepatitis B infections. 
Erythrocyte sedimentation rate was 
255 mm/h. Culture of a biopsy 
specimen from the cutaneous lesion on 
ordinary culture media was negative, 
although microscopic observation of 
the drainage ﬂ   uid showed acid-fast 
bacilli. This ﬁ   nding was conﬁ  rmed 
by a positive culture on LJ medium. 
A repeat specimen resulted in isolation 
of the same organism in pure culture. 
The patient was given amikacin and 
fully recovered in <1 month.
The isolates, i.e., HNTM1 and 
HNTM10, were subjected to pre-
liminary identiﬁ   cation and suscepti-
bility to common antimycobacterial 
agents for rapidly growing 
mycobacteria according to standard 
procedures (5,6). The isolates were then 
subjected to molecular identiﬁ  cation, 
which included PCR ampliﬁ  cation of 
a genus-speciﬁ  c region of the 65-kDa 
heat shock protein (hsp) gene (7) and the 
direct sequence analysis of 16S rDNA, 
hsp65, and rpoB genes as described 
(3,8,9). GenBank accession numbers 
for the gene sequences of HNTM1 as 
a representative isolate determined in 
this study are HM807280–HM807282.
The isolates we observed by acid-
fast staining of the specimens and 
recovered on LJ medium were a yellow 
pigmented photochromogenic species 
that grew rapidly at 25°C, 37°C, and 
42°C. They grew on MacConkey 
agar without crystal violet and LJ 
medium containing 5% NaCl; were 
positive for semiquantitative catalase, 
arylsulfatase activity in 14 days, and 
nitrate reduction; and were negative 
for urease activity, niacin production, 
tellurite and Tween hydrolysis, heat-
stable (68°C) catalase, and iron uptake. 
They were susceptible to amikacin, 
clarithromycin, doxycycline, sulfa-
methoxazole, streptomycin, imipenem, 
ciproﬂ   oxacin, isoniazid, and etham-
butol but resistant to rifampin.
The PCR ampliﬁ  cation of a 228-
bp genus-speciﬁ   c fragment of the 
hsp65 gene reliably conﬁ  rmed  that 
the isolates belonged to the genus 
Mycobacterium. The almost complete 
16S rDNA gene sequence (1,476 bp) 
and partial sequences of hsp65 and 
rpoB genes of the isolates showed 
the highest similarity of 99.86%, 
99.45%, and 99.7% with that of M. 
novocastrense reference strain. These 
values correspond to 2-nt differences 
for each gene.
Our report of 2 independent 
clinical cases might support evi-
dence the clinical relevance of M. 
novocastrense. Our ﬁ  ndings show that 
M. novocastrense, however rare its 
incidence might be, can cause infection 
in healthy and immunocompromised 
patients. However, because of the 
complexity of identifying nontuber-
culous mycobacteria, emphasis should 
be placed on the quality of regional 
laboratories for TB in developing 
countries to differentiate isolates to 
the species level.
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Geographic 
Expansion of 
Buruli Ulcer 
Disease, Cameroon
To the Editor: Buruli ulcer 
disease (BU) is a necrotizing skin 
disease caused by Mycobacterium 
ulcerans that affects mostly children 
in humid, tropical areas (1). The exact 
mode of M. ulcerans transmission 
remains unclear, although the role 
of water bugs has been supported by 
various observations and experimental 
studies (2,3). We report the 
identiﬁ   cation of a new BU-endemic 
area in Cameroon, the Bankim district, 
and specify ecologic and clinical 
characteristics of M. ulcerans infection 
in this area. These characteristics hint 
at the possible role of environmental 
changes (building of a dam several 
years ago) in the expansion of BU in 
this area.
Since 1969, only 1 BU-endemic 
area in Cameroon has been described: 
the Nyong River basin, where 
equatorial forest predominates (4). 
In 2004, clinically suspected cases 
of BU in the district of Bankim have 
been reported (5). This region differs 
from the ﬁ   rst BU-endemic area by 
geography and climate. Representing 
a transition between forested south 
and savanna north, this area has 
beneﬁ  ted from the building of a dam 
on the Mape River in 1989, which 
created an artiﬁ  cial lake of 3.2 billion 
m3 capacity.
From January 2007 through 
June 2009, all cases of skin lesions 
evocative of active BU were recorded 
as BU probable cases according to 
World Health Organization guidelines 
(6). During this period, 195 clinically 
suspected cases were reported from 
the Bankim health district (Figure). 
The overall median age for these 195 
patients was 19.5 years (interquartile 
range 10–37 years). No signiﬁ  cant 
difference in age was found according 
to gender, but a signiﬁ  cant trend of 
decreasing overall median age was 
found (20 years in 2007 to 12 years 
in 2009. The most frequent type of 
lesion was ulcer. Since March 2009, 
the Centre Pasteur of Cameroon has 
performed laboratory conﬁ  rmation 
for suspected BU cases: microscopic 
examination for acid-fast bacilli, 
culture, and M. ulcerans DNA 
detection by PCR (6). From April 
through June 2009, of 34 consecutive 
samples tested in the reference 
laboratory, 10 were positive for M. 
ulcerans by at least microscopy and 
PCR.
Whether BU is emerging in 
Bankim or is just a newly recognized 
preexisting disease is difﬁ  cult  to 
establish. However, that the incidence 
of BU in the region is increasing 
is unquestionable. The decreasing 
median age of patients since 2007 
might be consistent with emergence of 
BU as a new disease in Bankim. This 
observation could suggest either an 
increasing level of acquired immunity 
in the population, leading to protection 
correlated with age, or the expansion 
of risky sites for human infection with 
M. ulcerans.
During 1 week in January 2008, 
water bugs were collected from the 
artiﬁ  cial lake and water bodies located 
within or close to each community. 
A previously described sampling 
method was used (2). To detect M. 
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